Associate Professor Medicine, Harvard Medical School
Rheumatology
Dr. Nancy A. Shadick, MD
|
|
Give Review
Nancy Shadick practices Rheumatology. She graduated from NYU School of Medicine. She received awards:"America's Top Doctors", "Boston Magazine", "Boston Herald", "Fellow" and "Fellow (FACR)". Nancy A. Shadick is also a published MD. She has 43 paper published. The most recent paper is: Increased pretreatment serum IFN-/ ratio predicts non-response to tumour necrosis factor inhibition in rheumatoid arthritis. Nancy Shadick accepts Medicare payments and is registered with Medicare.gov.
Publications
- The impact of multimorbidity status on treatment response in rheumatoid Arthritis patients initiating disease-modifying anti-rheumatic drugs.
- Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid Arthritis.
- Effects of Achieving Target Measures in RA on Functional Status, Quality of Life and Resource Utilization: Analysis of Clinical Practice Data.
- Detection of Rheumatoid Arthritis-Interstitial Lung Disease is Enhanced by Serum Biomarkers.
- Clinical characteristics of RA patients with secondary SS and association with joint damage.
- Inconsistent Treatment with Disease-modifying Antirheumatic Drugs: A Longitudinal Data Analysis.
- Subgrouping of rheumatoid Arthritis patients based on pain, fatigue, inflammation and psychosocial factors.
- Rheumatoid Arthritis quality measures and radiographic progression.
- The influence of polygenic risk scores on heritability of anti-CCP level in RA.
- Flares in Rheumatoid Arthritis: Frequency and Management. A Report from the BRASS Registry.
- Associations of Smoking and Alcohol Consumption with Disease Activity and Functional Status in Rheumatoid Arthritis.
- A Randomized Controlled Trial of an Internal Family Systems-based Psychotherapeutic Intervention on Outcomes in Rheumatoid Arthritis: A Proof-of-Concept Study.
- Factors associated with attrition in a longitudinal rheumatoid Arthritis registry.
- Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid Arthritis.
- Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis.
- Validation of a novel multibiomarker test to assess rheumatoid Arthritis disease activity.
- PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis.
- Remission and radiographic outcome in rheumatoid Arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
- Pain persists in DAS28 rheumatoid Arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
- Erroneous augmentation of multiplex assay measurements in patients with rheumatoid Arthritis due to heterophilic binding by serum rheumatoid factor.
- Clinical predictors of erosion-free status in rheumatoid Arthritis: a prospective cohort study.
- Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid Arthritis differs by source of report and infection severity.
- A functional RANKL polymorphism associated with younger age at onset of rheumatoid Arthritis.
- Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid Arthritis.
- Rheumatoid Arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
- Behavioral and attitudes survey about Lyme Disease among a Brazilian population in the endemic area of Martha's Vineyard, Massachusetts.
- Low-dose aspirin in the primary prevention of rheumatoid Arthritis: the Women's Health Study.
- De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot.
- Investigation of candidate polymorphisms and disease activity in rheumatoid Arthritis patients on methotrexate.
- TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid Arthritis and asthma.
- Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid Arthritis.
- Biomarkers of inflammation and development of rheumatoid Arthritis in women from two prospective cohort studies.
- Vitamin E in the primary prevention of rheumatoid Arthritis: the Women's Health Study.
- Common variants at CD40 and other loci confer risk of rheumatoid Arthritis.
- HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.
- Two independent alleles at 6q23 associated with risk of rheumatoid Arthritis.
- A controlled trial of a novel primary prevention program for Lyme Disease and other tick-borne illnesses.
- Outcomes in rheumatoid Arthritis: incorporating the patient perspective.
- Strategies for primary and secondary prevention of Lyme Disease.
- C-reactive protein in the prediction of rheumatoid Arthritis in women.
- Principal components analysis corrects for stratification in genome-wide association studies.
- Development of a multi-biomarker disease activity test for rheumatoid Arthritis.
Schools
New York University School Of Medicine
Colum Presby Hospital
Brigham Womens Hospital
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
Conditions Treated
- Adhesive Capsulitis
- Ankylosing Spondylitis
- Arthritis
- Bursitis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Boston Herald
- Fellow
- Fellow (FACR)
Education
-
New York Presbyterian Hospital - Columbia Campus -
NYU School of Medicine
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1356307292 | |
| NPPES Provider LastName | SHADICK | |
| NPPES Provider FirstName | NANCY | |
| NPPES Provider ZIPCode | 024456002 | |
| NPPES Provider State | MA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 499.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356307292 |
| Last Name Of The Provider | SHADICK |
| First Name Of The Provider | NANCY |
| View All |
Similar Doctors
|
|
Dr. Sara R. Schoenfeld, MD |
|
|
Dr. Francine Ton Nghiem, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Plenge, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert H. Shmerling, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Deborah S. Collier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erika H. Noss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. I Cheng Ho, MD |
|
|
Dr. Minna J. Kohler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah B. Lieber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine Konya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caryn A. Libbey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace H. Lo, MD |
|
|
Dr. Gunnar Tomasson, MD
This Doctor is OpenDoctor Recommended.
|